Luigi Stasi

550 total citations
20 papers, 325 citations indexed

About

Luigi Stasi is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Luigi Stasi has authored 20 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Luigi Stasi's work include Synthesis and Biological Evaluation (5 papers), Chemical Synthesis and Analysis (3 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Luigi Stasi is often cited by papers focused on Synthesis and Biological Evaluation (5 papers), Chemical Synthesis and Analysis (3 papers) and Synthesis and Reactivity of Heterocycles (3 papers). Luigi Stasi collaborates with scholars based in Italy, United Kingdom and Sweden. Luigi Stasi's co-authors include Patricia Arnaiz, Aleksander A. Mathé, Roberto Arban, Laura Caberlotto, Philip Gerrard, David A. York, Antonio Giordani, Christy L. White, N. Upton and George A. Bray and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Luigi Stasi

19 papers receiving 322 citations

Peers

Luigi Stasi
Lynn Resnick United States
Lesley A. Howell United Kingdom
Kirsten L. Miller United States
Thuy-Anh Tran United States
Suzie A. Ferreira United States
Alan E. Fletcher United States
Lisa Dvorak United States
Ta Kung Chen United States
Lynn Resnick United States
Luigi Stasi
Citations per year, relative to Luigi Stasi Luigi Stasi (= 1×) peers Lynn Resnick

Countries citing papers authored by Luigi Stasi

Since Specialization
Citations

This map shows the geographic impact of Luigi Stasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Stasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Stasi more than expected).

Fields of papers citing papers by Luigi Stasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Stasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Stasi. The network helps show where Luigi Stasi may publish in the future.

Co-authorship network of co-authors of Luigi Stasi

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Stasi. A scholar is included among the top collaborators of Luigi Stasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Stasi. Luigi Stasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruffaerts, Jeffrey, Luigi Stasi, Bénédicte Lallemand, et al.. (2023). Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property Optimization. ACS Medicinal Chemistry Letters. 14(11). 1582–1588. 5 indexed citations
2.
Leveridge, Melanie, C. Edge, Mike Rees, et al.. (2015). A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease Using RapidFire Mass Spectrometry. SLAS DISCOVERY. 21(2). 145–155. 28 indexed citations
3.
Stasi, Luigi, et al.. (2013). Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(9). 2653–2658. 8 indexed citations
4.
Stasi, Luigi, et al.. (2013). Prostaglandin EP4Antagonists. Pharmaceutical Patent Analyst. 2(3). 387–397. 8 indexed citations
6.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2011). Synthesis and Structure–Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold. Journal of Medicinal Chemistry. 54(20). 7165–7175. 25 indexed citations
7.
Cappelli, Andrea, Salvatore Valenti, Germano Giuliani, et al.. (2010). Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4‐c]quinolin‐1‐one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors. ChemMedChem. 5(5). 739–748. 26 indexed citations
8.
Gianotti, Massimo, Corrado Corti, Romano Di Fabio, et al.. (2010). Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders. Bioorganic & Medicinal Chemistry Letters. 20(17). 5069–5073. 11 indexed citations
9.
Leslie, Colin P., Matteo Biagetti, Steven M. Bromidge, et al.. (2010). Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist. Journal of Medicinal Chemistry. 53(23). 8228–8240. 10 indexed citations
10.
Stasi, Luigi, et al.. (2010). Synthesis of 3,3-disubstituted oxetane building blocks. Tetrahedron Letters. 52(5). 565–567. 10 indexed citations
11.
Rienzo, Francesca De, Puneet Saxena, Gianfranco Caselli, et al.. (2009). Progress Towards the Identification of New Aggrecanase Inhibitors. Current Medicinal Chemistry. 16(19). 2395–2415. 19 indexed citations
12.
Bromidge, Steven M., Barbara Bertani, Laurie Gordon, et al.. (2008). 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5653–5656. 23 indexed citations
13.
Leslie, Colin P., Romano Di Fabio, Simone Braggio, et al.. (2006). Novel carbazole derivatives as NPY Y1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(4). 1043–1046. 15 indexed citations
14.
Mathé, Aleksander A., Patricia Arnaiz, Luigi Stasi, et al.. (2006). Anxiolytic-like effect of the selective Neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides. 27(12). 3202–3207. 63 indexed citations
15.
White, Christy L., Yasuyuki Ishii, N. Upton, et al.. (2005). Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity. Peptides. 26(11). 2331–2338. 43 indexed citations
16.
Saladino, Raffaele, Luigi Stasi, Rosario Nicoletti, Claudia Crestini, & Maurizio Botta. (1999). Umpolung of Reactivity of Lithium Trimethylsilyldiazomethane at the C-5 Position of 6-Substituted Uracil Derivatives. European Journal of Organic Chemistry. 1999(11). 2751–2755. 2 indexed citations
17.
Botta, Maurizio, et al.. (1999). Recent Advances in the Synthesis of 6-Vinyl-N,N-Dialkylcytosine Derivatives. Nucleosides and Nucleotides. 18(4-5). 555–556.
18.
Stasi, Luigi & George Just. (1999). Reactions of phosphite triesters with alkyl boranes. Tetrahedron Letters. 40(12). 2283–2286. 3 indexed citations
19.
Saladino, Raffaele, et al.. (1998). Reactivity of Dimethylphenylsilyllithium toward 5- and 6-Substituted 1,3-Dimethyluracil Derivatives. Heterocycles. 48(12). 2601–2601. 2 indexed citations
20.
Saladino, Raffaele, Luigi Stasi, Claudia Crestini, Rosario Nicoletti, & Maurizio Botta. (1997). Reactivity of lithium trimethylsilyldiazomethane and diazomethane toward the 5,6-double bond of uracil and uridine derivatives. Tetrahedron. 53(20). 7045–7056. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026